Does Marijuana Help Neuropathy?
Research and patient surveys suggest marijuana may meaningfully reduce neuropathy pain. THC addresses central pain sensitization in the spinal cord and brain, while CBD targets peripheral neuroinflammation in nerve tissue. Together they address neuropathy from both directions.
Neuropathy involves two overlapping components. Peripheral nerve damage triggers local neuroinflammation, which CBD addresses through CB2 receptor modulation in nerve tissue and immune cells. Over time, chronic neuropathy also produces central sensitization, where the spinal cord and brain become hypersensitized to nerve pain signals. THC’s CB1 receptor activity in the central pain processing pathway addresses this component directly. Multiple clinical studies have found cannabis with THC more effective than placebo for neuropathic pain, and a 2020 study found topical CBD produced significant reductions in peripheral neuropathy symptoms.
The strongest coverage for neuropathy combines a systemic product for central sensitization with a topical cream on the affected area for local nerve receptor activation. Indica-dominant strains and products with beta-caryophyllene in the terpene profile are best suited for neuropathy because beta-caryophyllene directly activates CB2 receptors in nerve tissue. Starting with CBD or a low-dose balanced product and adding THC gradually is the typical approach for neuropathy patients new to cannabis, since low doses of THC often produce meaningful nerve pain relief before the amounts needed for significant intoxication.
This content is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. TribeTokes products are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before using cannabinoid products, especially if you take prescription medications.